Solara Active Pharma Sciences Limited (SOLARA.NS)
INR 509.75
(4.26%)
INR 509.75
(4.26%)
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2023 | -1.65 Billion INR | -26.12% |
| 2022 | 6.54 Billion INR | 22.94% |
| 2021 | 5.32 Billion INR | -33.91% |
| 2020 | 8.06 Billion INR | 28.59% |
| 2019 | 6.26 Billion INR | 8.97% |
| 2018 | 5.75 Billion INR | 681.38% |
| 2017 | 736.27 Million INR | -83.21% |
| 2016 | 4.38 Billion INR | 0.0% |
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 Q1 | 818.3 Million INR | -20.29% |
| 2024 Q2 | 1.75 Billion INR | 18.55% |
| 2023 Q4 | 1.02 Billion INR | 285.34% |
| 2023 FY | 4.83 Billion INR | -26.12% |
| 2023 Q1 | 1.6 Billion INR | -14.81% |
| 2023 Q2 | 1.87 Billion INR | 17.08% |
| 2023 Q3 | -553.9 Million INR | -129.51% |
| 2022 Q2 | 1.48 Billion INR | 10.8% |
| 2022 Q4 | 1.88 Billion INR | 2.63% |
| 2022 FY | 6.54 Billion INR | 22.94% |
| 2022 Q1 | 1.34 Billion INR | 199.0% |
| 2022 Q3 | 1.83 Billion INR | 23.08% |
| 2021 Q2 | 2.14 Billion INR | -5.55% |
| 2021 FY | 5.32 Billion INR | -33.91% |
| 2021 Q1 | 2.27 Billion INR | 56.62% |
| 2021 Q4 | 449.7 Million INR | -2.62% |
| 2021 Q3 | 461.8 Million INR | -78.47% |
| 2020 Q1 | 1.98 Billion INR | 178.11% |
| 2020 Q4 | 1.45 Billion INR | -39.33% |
| 2020 FY | 8.06 Billion INR | 28.59% |
| 2020 Q2 | 2.23 Billion INR | 12.41% |
| 2020 Q3 | 2.39 Billion INR | 6.98% |
| 2019 Q4 | 714.6 Million INR | -63.44% |
| 2019 Q3 | 1.95 Billion INR | 7.7% |
| 2019 Q2 | 1.81 Billion INR | 1.71% |
| 2019 FY | 6.26 Billion INR | 8.97% |
| 2019 Q1 | 1.78 Billion INR | 130.63% |
| 2018 FY | 5.75 Billion INR | 681.38% |
| 2018 Q4 | 773.8 Million INR | -57.17% |
| 2018 Q3 | 1.8 Billion INR | 8.67% |
| 2018 Q2 | 1.66 Billion INR | 10.13% |
| 2018 Q1 | 1.5 Billion INR | 1.19% |
| 2017 Q2 | 156.71 Million INR | -87.7% |
| 2017 Q1 | 1.27 Billion INR | 0.0% |
| 2017 FY | 736.27 Million INR | -83.21% |
| 2017 Q4 | 1.49 Billion INR | 0.0% |
| 2016 FY | 4.38 Billion INR | 0.0% |
| Name | Gross Profit | Gross Profit Difference |
|---|---|---|
| Alembic Pharmaceuticals Limited | 26.78 Billion INR | 106.183% |
| Hester Biosciences Limited | 1.27 Billion INR | 230.012% |
| Aarti Drugs Limited | 8.31 Billion INR | 119.912% |
| Aarti Pharmalabs Limited | 5.83 Billion INR | 128.397% |
| Albert David Limited | 1.4 Billion INR | 217.599% |
| Alembic Limited | 1 Billion INR | 265.572% |
| Alkem Laboratories Limited | 52.29 Billion INR | 103.166% |
| Bafna Pharmaceuticals Limited | 452.15 Million INR | 466.226% |
| Bajaj HealthCare Limited | 1.47 Billion INR | 212.508% |
| Biofil Chemicals and Pharmaceuticals Limited | 12.54 Million INR | 13299.681% |
| Brooks Laboratories Limited | 65.62 Million INR | 2623.468% |
| Eris Lifesciences Limited | 10.42 Billion INR | 115.881% |
| FDC Limited | 6.58 Billion INR | 125.142% |
| Glenmark Life Sciences Limited | 12.43 Billion INR | 113.319% |
| Gufic Biosciences Limited | 4.07 Billion INR | 140.648% |
| Hikal Limited | 5.95 Billion INR | 127.793% |
| Ind-Swift Limited | 2.17 Billion INR | 176.22% |
| Innova Captab Limited | 3.46 Billion INR | 147.797% |
| IOL Chemicals and Pharmaceuticals Limited | 4.71 Billion INR | 135.089% |
| Jagsonpal Pharmaceuticals Limited | 652.59 Million INR | 353.743% |
| Jubilant Pharmova Limited | 19.64 Billion INR | 108.43% |
| Lincoln Pharmaceuticals Limited | 1.88 Billion INR | 187.759% |
| Lupin Limited | 125.09 Billion INR | 101.324% |
| Mangalam Drugs & Organics Limited | 691.19 Million INR | 339.571% |
| Medico Remedies Limited | 262.14 Million INR | 731.676% |
| Morepen Laboratories Limited | 6.16 Billion INR | 126.876% |
| Nectar Lifesciences Limited | 4.82 Billion INR | 134.331% |
| Orchid Pharma Limited | 2.32 Billion INR | 171.366% |
| Procter & Gamble Health Limited | 5.78 Billion INR | 128.642% |
| RPG Life Sciences Limited | 2.48 Billion INR | 166.689% |
| Kilitch Drugs (India) Limited | 620.47 Million INR | 366.875% |
| Sigachi Industries Limited | 2 Billion INR | 182.701% |
| Suven Pharmaceuticals Limited | 4.12 Billion INR | 140.16% |
| Themis Medicare Limited | 2.42 Billion INR | 168.425% |
| Unichem Laboratories Limited | 4.86 Billion INR | 134.037% |
| Vaishali Pharma Limited | 90.32 Million INR | 1933.309% |
| Wanbury Limited | 1.73 Billion INR | 195.681% |
| Windlas Biotech Limited | 1.33 Billion INR | 223.685% |
| ZIM Laboratories Limited | 1.26 Billion INR | 230.611% |
| Ind-Swift Laboratories Limited | 4.13 Billion INR | 140.063% |
| Ipca Laboratories Limited | 48.58 Billion INR | 103.408% |
| Sun Pharmaceutical Industries Limited | 258.48 Billion INR | 100.641% |
| Venus Remedies Limited | 2.18 Billion INR | 175.869% |
| Sakar Healthcare Limited | 699.58 Million INR | 336.697% |
| Aurobindo Pharma Limited | 109.54 Billion INR | 101.512% |
| Divi's Laboratories Limited | 32.44 Billion INR | 105.105% |
| AstraZeneca Pharma India Limited | 6.22 Billion INR | 126.611% |
| Mankind Pharma Limited | 42.19 Billion INR | 103.924% |
| Sequent Scientific Limited | 2.97 Billion INR | 155.591% |
| Laurus Labs Limited | 15.44 Billion INR | 110.719% |
| Neuland Laboratories Limited | 8.24 Billion INR | 120.077% |
| J. B. Chemicals & Pharmaceuticals Limited | 15.25 Billion INR | 110.852% |
| Glenmark Pharmaceuticals Limited | 69.34 Billion INR | 102.388% |
| Zydus Lifesciences Limited | 125.21 Billion INR | 101.322% |
| Amrutanjan Health Care Limited | 2.09 Billion INR | 179.077% |
| Wockhardt Limited | 7.72 Billion INR | 121.449% |
| Bal Pharma Limited | 770.19 Million INR | 314.998% |
| Dr. Reddy's Laboratories Limited | 163.6 Billion INR | 101.012% |
| Bliss GVS Pharma Limited | 3.69 Billion INR | 144.809% |
| Par Drugs and Chemicals Limited | 529.13 Million INR | 412.944% |
| Caplin Point Laboratories Limited | 9.2 Billion INR | 117.986% |
| Shilpa Medicare Limited | 3.56 Billion INR | 146.489% |
| Valiant Laboratories Limited | 138.02 Million INR | 1299.675% |
| Ajanta Pharma Limited | 21.06 Billion INR | 107.861% |
| Aarey Drugs & Pharmaceuticals Limited | 113.02 Million INR | 1565.022% |
| Granules India Limited | 16.79 Billion INR | 109.857% |
| Medicamen Biotech Limited | 495.49 Million INR | 434.191% |
| Syncom Formulations (India) Limited | 559.5 Million INR | 395.959% |
| Piramal Enterprises Limited | 8.04 Billion INR | 120.587% |
| Torrent Pharmaceuticals Limited | 46.75 Billion INR | 103.541% |
| NATCO Pharma Limited | 25.73 Billion INR | 106.434% |
| Suven Life Sciences Limited | -200.79 Million INR | -724.664% |
| Krebs Biochemicals & Industries Limited | -108.74 Million INR | -1422.709% |
| Strides Pharma Science Limited | 14.38 Billion INR | 111.509% |
| Indoco Remedies Limited | 8.04 Billion INR | 120.588% |
| Alpa Laboratories Limited | 188.89 Million INR | 976.625% |
| Lasa Supergenerics Limited | 121.02 Million INR | 1468.173% |
| Sun Pharma Advanced Research Company Limited | 391.06 Million INR | 523.432% |